论文部分内容阅读
目的:探讨对肥胖2型糖尿病利用艾塞那肽进行治疗所取得的临床效果。方法:选择曾在我院进行治疗的120例肥胖2型糖尿病患者,将这些患者随机分为数量相等的两组,将其分别记作观察组与对照组,对照组中患者以胰岛素注射方法来进行治疗,观察组中患者在二甲双胍基础上,以艾塞那肽皮下注射方法来进行治疗,观察两组患者的治疗效果以及所出现的不良反应。结果:在完成治疗之后,观察两组患者的临床治疗效果,观察组与对照组中患者的各种临床症状均得到一定程度改善,但观察组中患者的改善程度明显优于对照组中患者,两组患者之间有显著差异存在;观察两组患者在治疗过程中均未出现严重不良反应,均顺利完成治疗,两组患者之间无显著差异存在。结论:对肥胖2型糖尿病以艾塞那肽进行治疗能够取得较好的临床治疗效果,能够对患者血糖进行有效控制,并且能够有效控制其体质量,对脂代谢进行有效改善,有着十分重要的临床作用与意义,在进行进一步推广应用。
Objective: To investigate the clinical effect of exenatide on obese type 2 diabetes. Methods: A total of 120 obese type 2 diabetic patients who had been treated in our hospital were enrolled. These patients were randomly divided into two equal groups, which were respectively recorded as observation group and control group. Patients in the control group were injected with insulin The patients in the observation group were treated with exenatide subcutaneously on the basis of metformin, and the treatment effect and the adverse reactions of the two groups were observed. Results: After completing the treatment, the clinical effects of the two groups of patients were observed. The clinical symptoms of the patients in the observation group and the control group all improved to some extent. However, the improvement in the observation group was significantly better than that in the control group. There was a significant difference between the two groups of patients; observed two groups of patients in the course of treatment did not appear serious adverse reactions were successfully completed treatment, there was no significant difference between the two groups. Conclusion: The treatment of exenatide in obese type 2 diabetic patients can achieve better clinical therapeutic effect, which can effectively control the blood glucose of patients with type 2 diabetes, and can effectively control the body weight and effectively improve the lipid metabolism. It is very important Clinical role and significance, in the further promotion and application.